Key result
Anti-CCP antibodies demonstrate high specificity for diagnosing rheumatoid arthritis and may help predict disease persistence and radiographic joint damage, though their sensitivity in early arthritis remains debated.
Why the study?
Does Anti-CCP testing improve diagnostic accuracy and prognostic evaluation in patients with rheumatoid arthritis compared to rheumatoid factor?
Population
Patients with rheumatoid arthritis (RA) and early arthritis
Comparison
Anti-cyclic citrullinated peptide antibody testing vs Rheumatoid factor (RF) testing
Design
Review
Authors
Loading...
May support Anti-CCP testing for RA specificity and erosive prognosis in RF-negative patients; leaves open early sensitivity and comparative utility versus RF.
Does Anti-CCP testing improve diagnostic accuracy and prognostic evaluation in patients with rheumatoid arthritis compared to rheumatoid factor?
Anti-CCP antibodies offer high specificity for diagnosing rheumatoid arthritis and provide valuable prognostic information for predicting erosive disease, especially in RF-negative patients.
Erre et al. (2011) conducted a review in Rheumatoid arthritis. Anti-CCP antibodies testing vs. Rheumatoid Factor (RF) was evaluated. Anti-CCP antibodies demonstrate high specificity for diagnosing rheumatoid arthritis and may help predict disease persistence and radiographic joint damage, though their sensitivity in early arthritis remains debated.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: